Background: Whilst validated quality-of-recovery (QoR) tools exist for general surgery, there is no specific obstetric equivalent. We aimed to develop and evaluate a modified QoR score after elective Caesarean delivery. Methods: Twenty-two obstetric specific items were selected following review and modification of the QoR-40 survey by 16 experts and interviews with 50 stakeholders. Item selection was based on relevance to Caesarean delivery and endorsement by >66% of stakeholders. Items were tested on women pre-delivery, at 24 h, and 25 h post-delivery. An 11-item obstetric-specific QoR score (ObsQoR-11) was created based on correlation with a numerical rating scale (NRS) of global health status (r>0.20) at all time points. Reliability, responsiveness, acceptability, and feasibility were tested. Results: One hundred and fifty-two women responded to the 22-item questionnaire pre-delivery (complete in 146), 100 at 24 h, and 10 at 25 h. The ObsQoR-11 correlated with the global health status NRS (r¼0.53; 95% confidence interval: 0.43e0.62; P<0.0001) and discriminated good vs poor recovery (NRS score 70 vs <70 mm) at 24 h. There was a negative correlation between the ObsQoR-11 score at 24 h and hospital length of stay (r¼e0.39; P¼0.003). ObsQoR-11 was reliable (internal consistency: 0.85; split-half 0.76; testeretest intra-class correlation coefficient r i >0.6 in 82% of items) and responsive (Cohen effect size: 1.36; standardised response mean: 0.85). A longer 22-item ObsQoR had high (97%) completion rates and short (median: 2 min) completion times. Conclusions: The ObsQoR-11 provides a valid, reliable, and responsive global assessment of recovery after elective Caesarean delivery.
Editor's key points
A patient-centred global measure of quality of recovery can be used to evaluate new treatments in perioperative practice. A surgery-specific, in this case elective Caesarean delivery, quality-of-recovery measurement tool may offer additional value. Here, the 11-item ObsQoR-11, derived from the 40-item QoR-40, was found to be valid, reliable, and responsive to changes in health status. The ObsQoR-11 is thus a suitable outcome measure in Caesarean delivery.
Recovery after Caesarean delivery (CD) is a complex process, dependent on patient, surgical and anaesthetic characteristics, and is also influenced by the occurrence of postoperative complications. Postoperative outcome measures have traditionally focused on mortality and morbidity, which, although important, do not describe the patient experience or quality of recovery (QoR) from surgery.
The QoR-40 1 and QoR-15 surveys 2 were developed to evaluate patient-reported recovery outcome measures after surgery. These scoring tools accurately evaluate postoperative recovery by measuring key domains, including: pain, physical comfort, physical independence, psychological support, and emotional state. They were however, developed and validated in non-obstetric inpatients and day-case surgery populations. 2, 3 Consequently, they contain recovery aspects not relevant to CD (mostly performed under neuraxial anaesthesia) and do not include key items, such as ability to care for the newborn child, that are synonymous with good postoperative recovery after CD. To date, no validated scoring tools exist evaluating postoperative recovery after CD. 4, 5 Functional recovery outcome measures after CD generally focus on pain scores as the single most important dimension of postoperative recovery. 6 Functional scales measuring recovery domains beyond pain, including: the QoR-40 survey, rating scales of global health or quality of life, and rehabilitation scores, fail to include multiple aspects relevant to recovery in the early postpartum period.
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This study aimed to develop and evaluate an obstetricspecific QoR score. Specifically, we aimed to adapt the QoR-40 to measure patient-centred dimensions of functional recovery relevant to the early postpartum period after CD and test reliability, responsiveness, clinical acceptability, and feasibility of this devised scoring tool.
Methods
We conducted a prospective observational study of term women undergoing elective CD between October 2016 and July 2017 at a UK university hospital. Local research office designated the study as service evaluation, and it was therefore exempt from ethical approval requirement, consistent with a previous study performed at our institution. 3 At our institution, women are instructed to fast for 6 h before surgery and are encouraged to drink until 2 h before surgery. Our institutional analgesic regimen includes: intrathecal diamorphine 300 mg administered via either single-shot spinal or combined spinaleepidural, regular paracetamol 1 g, and ibuprofen 400 mg four times daily after operation, and, as required, oral morphine 20 mg 4 hourly on the day of surgery and dihydrocodeine 30 mg 6 hourly from Day 1 after CD for breakthrough pain. Women are also routinely prescribed i.v. ondansetron 4e8 mg and cyclizine 50 mg 8 hourly as required after surgery. Women are encouraged to mobilise 6 h after spinal anaesthesia, and a trial without urinary catheter is attempted 8 h after neuraxial drug administration.
We elected to utilise the QoR-40 scoring tool as a template from which the Obstetric Quality of Recovery-11 score (ObsQoR-11) was developed. Formulation of the ObsQoR-11 scoring tool occurred in five stages (Table 1 ; Fig. 1 ): (i) removal of non-obstetric and non-neuraxial relevant items, resulting in 19 remaining items; (ii) expert evaluation and addition of 12 obstetric-and neuraxial-related items; (iii) stakeholder evaluation and ranking of the 31 items to select those identified as most important to recovery after elective CD, and those items with >2/3 stakeholder support led to a 22-item scale; (iv) the ObsQoR-22 questionnaire was then tested against a numerical rating scale (NRS) of global health status on term women scheduled for elective CD preoperatively, at 24 h, and a subset a further 1 h (i.e. 25 h) after surgery; and (v) items with a significant correlation (r>0.2) with an NRS of global health status were retained, resulting in an 11-item ObsQoR-11 questionnaire. We conducted further post hoc factor analysis on ObsQoR-22 items as outlined below.
Stages (i) and (ii) occurred through interviews of 16 experts: four obstetric anaesthetists (C.S., M.C., J.D., and P.S.), three obstetricians, three midwives, three recovery nurses, and three post-CD women (Fig. 1) . The resultant 31 items were then evaluated by a new group of 50 stakeholders: 13 term pregnant women, 4 partners, 13 anaesthetists, 11 midwives, and 9 obstetricians. The stakeholders were asked to select items important for evaluating recovery after elective CD. During this phase, the 31 stakeholder items were ranked according to popularity. We also sought feedback to evaluate whether any modifications were required to improve clarity of items. The stakeholders were encouraged to add to the list of recovery items if necessary. Additional items were considered further in item list development if added by >1 stakeholder. Twentytwo of the 31 items were chosen by >2/3 stakeholders resulting in a 22-item ObsQoR questionnaire, which was evaluated further. The >2/3 threshold was chosen to allow inclusion of more than 20 items, as advised by expert opinion (M.C.).
For stage (iv), women were approached on the morning of their scheduled CD and invited to complete the 22-item ObsQoR questionnaire before and after their operation. The inclusion criteria were: women undergoing elective CD, 37 weeks gestational age, and surgery performed under either neuraxial anaesthesia or general anaesthesia. The exclusion criteria were: age <18 yr, patient refusal, and inability to read or understand written English. Recruitment days corresponded to investigator availability over the study period.
Baseline patient characteristic and clinical data were collected at the time of enrolment for descriptive purposes. Upon recruitment and before CD, women were asked by investigators to complete the 22-item ObsQoR questionnaire, rating each item on an 11-point numerical Likert scale (0¼strongly negative; 10¼strongly positive; see Supplementary  Fig. S1 ). Women were also asked to rate their baseline status utilising a global health NRS, represented as a 100 mm line and ruler, marked at each end with anchors 'worst imaginable health state' to 'best imaginable health state', and with 'sad' or 'happy' stylised representations of faces. They were then asked to repeat the 22-item ObsQoR questionnaire and overall global health NRS at 24 h after CD. A subset of women were We conducted factor analysis and found that 21 items (including all 11 items of the ObsQoR-11) were identified from the original 22 items selected in the stage (iii). There were four underlying factors, and these four factors explained more than 93% of the variance. After the development of the ObsQoR-11 questionnaire, the scoring tool was evaluated post hoc to determine the following:
(i) Validity as a measure of accuracy Although not specifically tested on an independent sample of women, ObsQoR-11 was assessed by two subtypes of construct validity: convergent and discriminant validity, and content validity, which are outlined as follows: (a) Convergent and discriminant validity: ObsQoR-11 scores were compared with 100 mm global health status NRS assessment scores of 70 vs <70 mm at 24 h, respectively. (b) Content validity: ObsQoR-11 scores were assessed for correlation with the length of hospital stay (time from admission to discharge from hospital) and age of women. Given the well-established increase in perioperative risk with advancing maternal age, we hypothesised that age could negatively correlate with QoR. 
Statistical analysis
The sample size for this study was guided by previous studies, as power calculation is not reliable for correlation analysis.
2 analysis was used to compare stakeholder groups in the formulation phase. Continuous data were tested for normality using the ShapiroeWilk and KolmogoroveSmirnov normality tests; all percentages were rounded up to the nearest integer.
Correlations between the 22-item ObsQoR questionnaire items (which contain ObsQoR-11 items) and global health NRS scores were determined using Spearman rank correlation coefficients (r). Non-parametric data were compared using Wilcoxon signed-rank test. Internal consistency was measured with Cronbach's alpha. 11 The testeretest reliability was measured by intra-class correlation coefficient. Post hoc factor analysis was performed on the 22-item ObsQoR. We selected factors based on eigenvalue >1. Items with loading >0.4 were selected for each factor. The internal consistency of each factor was assessed by Cronbach's alpha. Statistical analysis was performed using GraphPad Software (7.0; USA) and SAS Institute, USA. The null hypothesis was rejected if the two-tailed P-value was <0.05.
Results
The formulation of the ObsQoR-11 from QoR-40 items is summarised in Table 1 . Thirty-one recovery items were initially included from five dimensions: pain, physical comfort, physical independence and care of the neonate, psychological support, and emotional state. The items subsequently removed after endorsement by <2/3 of stakeholders are outlined in Supplementary Table S1 and Supplementary Figure S2 . The resultant 22-item ObsQoR questionnaire is shown in Supplementary Figure S1 . Based on feedback from multiple patients that found it difficult to define and distinguish between 'nausea' and 'vomiting', these items were combined to form a single item 'nausea or vomiting', before inclusion in the 22-item ObsQoR version. No additional items were added at this stage, as no new items were suggested by more than one stakeholder. We recruited 152 women to the next stage of the study, all of whom filled out the 22-item version of the ObsQoR questionnaire prior to CD, 100 at 24 h and 10 at 25 h after surgery; six questionnaires had incomplete or missing data, and were therefore excluded from the analysis, leaving 146 complete pre-CD questionnaires. There were two incomplete questionnaires filled at 24 h, leaving 98 complete questionnaires and no incomplete data at 25 h. The clinical characteristics of women who filled the preoperative 22-item ObsQoR questionnaire are presented in Table 2 . The final 11 items included in the ObsQoR-11 were determined by excluding ObsQoR items from the combined pre-CD and 24 h post-CD questionnaires that failed to achieve a Spearman correlation of 0.2 to global health NRS scores at their corresponding time point (Supplementary Table S2 ; Fig. 2) .
A post hoc factor analysis of the 22-item ObsQoR identified four underlying factors, which explained more than 93% of the variance. A Scree plot of factor loading is provided in Supplementary Figure S3 . Item clustering in the four factors is outlined as follows, with items included in ObsQoR-11 distinguished in italics:
(i) Factor 1: shivering, dizziness, difficulty breathing, nausea or vomiting, headache, severe pain, feeling depressed, itchy, and perineal pain (ii) Factor 2: ability to communicate with staff, communicate with family, understand instructions, hold baby, feed baby, and feeling in control (iii) Factor 3: personal hygiene, ability to pass urine, mobilise independently, and full sensation to the body (iv) Factor 4: feeling comfortable and moderate pain Table 2) . ObsQoR-11 at 24 h had a negative correlation with duration of hospital stay (r¼e0.39; P¼0.003). There was a positive association between preoperative ObsQoR-11 and maternal age (r¼0.22; P¼0.027), but not to 24 h post-ObsQoR-11 scores (r¼e0.13; P¼0.31).
The inter-item correlation matrix for the ObsQoR-11 is presented in Table 3 . The split-half reliability was 0.76. The testeretest reliability of the ObsQoR-11 items was r i >0.6 in 82% of items and >0.5 in the remaining items, suggesting adequate repeatability and reliability. The percentage of women achieving the highest possible ObsQoR-11 score was 6% (n¼8) before operation and 0% (n¼0) at 24 h postoperatively; therefore, no floor or ceiling effects of the questionnaire were demonstrated (Supplementary Fig. S4 ). The ObsQoR-11 scores were negatively skewed (levels of skewness were e1.89 preoperative and e0.78 at 24 h postoperatively), indicating that the majority of the ObsQoR-11 total scores were in the upper half of the scale (>55).
Responsiveness to change for the ObsQoR-11 was excellent (Cohen effect size: 1.36), indicating an important change from pre-to post-CD. The standardised response mean was 0.85, which also indicates a large effect (Table 4 ). There was a significant difference between the pre-and 24 h postoperative ObsQoR-11 scores (median difference: e14; P<0.0001), supporting clinical utility (Table 4) . Box plots of the total ObsQoR-11 pre-and post-CD are presented in Supplementary Figure S5 .
Although the clinical acceptability and feasibility of the ObsQoR-11 were not formally assessed, there were no refusals to complete the longer 22-item ObsQoR questionnaire with all of those approached agreeing to complete the questionnaires pre-CD and post-CD. One hundred (66%) women completed both the pre-and post-CD 22-item ObsQoR questionnaires; drop out was attributable to early discharge or absence at the time of interviewer attendance. Eight questionnaires (six pre-CD and two post-CD) were excluded from the analysis because of incomplete data, therefore attaining a 97% inclusion rate overall. The median time [IQR] taken to complete the 22-item ObsQoR questionnaire (n¼93) was 2 [2e3] min, range: 1e10 min.
Discussion
This study developed and evaluated an obstetric-specific recovery scoring tool, the ObsQoR-11, for use in patients undergoing elective CD. The ObsQoR-11 performed well in measures of reliability, responsiveness, clinical acceptability, and feasibility. There was moderate correlation of 24 h ObsQoR-11 scores to 24 h global health NRS scores. However, the ObsQoR-11 was not independently evaluated on a patient sample, and therefore, future work is needed to validate ObsQoR-11 and determine its generalisability. The post hoc factor analysis confirmed that the selected 11 items contributed significantly to the four underlying factors. Factor 1 represents physical comfort and pain. Factor 2 covers both physical independence and emotional state. Factor 3 represents physical independence, and Factor 4 is a supplement to Factor 1. Recovery after surgery is a multidimensional process, the definition of which varies from clinician or patient perspective. Clinically, our focus has been to achieve the functions necessary to allow for early discharge from hospital. However, more recently, assessment tools of recovery have expanded from single one-dimensional measures of physiological variables to more continuous holistic assessments, including physical, nociceptive, emotive, cognitive, and functional outcomes. 12, 13 Available recovery assessment tools are heterogeneous in content and timing of assessment, with a combination of subjective and objective outcomes, and composite and dichotomous scoring. The currently available recovery assessment tools are not extensively validated for use in the obstetric population, and therefore, may be irrelevant for the elective CD population. 13 Recovery scoring tools have been shown to be sensitive in detecting clinically important differences in recovery after non-obstetric surgery.
14 Perioperative interventions that result in a change of 0.9 for the QoR score, 8.0 for QoR-15, or 6.3 for QoR-40 signify a clinically important improvement or deterioration.
14 Whilst the QoR-40 is a well-established scoring tool, 1 it takes approximately 10 min to complete. The previous QoR scales and other scores described in the literature, including short-term quality of life, 8 the surgical recovery index, 15 and recovery of bowel function scoring tools, 16 were not specifically designed to measure recovery in the immediate postoperative period, and omit pertinent items regarding recovery following Caesarean delivery. NRS scores for global health and pain scores, although quick to measure, do not provide a holistic indication of patient-reported functional recovery. 6, 7 To develop an obstetric-specific QoR score, we started with a broad selection of recovery items, and then evaluated and refined the tool in five stages. ObsQoR-11 contains no items from the 'psychological support' domain, which could imply that recovery factors relating to self-efficacy and functional ability are more important for CD-related health than the perceived support from staff or relatives during hospitalisation. Post hoc assessment of reliability, responsiveness, clinical acceptability, and feasibility of ObsQoR-11 appears to be very good to excellent, which is encouraging for future validation studies. ObsQoR-11 can discriminate between good and poor postoperative recovery in patients undergoing elective CD, without floor and ceiling effects. 17 A perfect final ObsQoR-11 score is 110, which was not achieved by any woman assessed at 24 h after surgery. A 24 h ObsQoR-11 score of 100 is associated with a 'good' health status at 24 h (NRS 70), and therefore, a good recovery, whereas a median score of 87 is associated with a 'poorer' health status (NRS <70) or poor recovery outcome after elective CD in this patient cohort. 2 The post hoc assessment of ObsQoR-11 convergent validity revealed a moderate correlation to global health NRS score, comparable with QoR-15 and the more extensive QoR-40, used for general postoperative recovery evaluation. 12 However, the ObsQoR-11 correlation with global health NRS fell short of the >0.6 value recommended for scoring tools. 18 Yet, the upper limit of the 95% CI does include 0.6, suggesting ObsQoR-11 may have utility in predicting QoR as measured by the NRS of global health status. The global health NRS score has not been psychometrically evaluated and may overrate the general wellbeing in obstetric patients. Therefore, it may not be the ideal score or 'gold standard' to compare ObsQoR-11 with. We also demonstrated that ObsQoR-11 negatively correlates with hospital stay, further supporting the use of this tool in measuring a clinically important outcome related to recovery. Interestingly, ObsQoR-11 correlated positively with age before surgery, but not after, which could indicate better psychological preparation for CD with age or prior experience of childbirth. Discriminant validity was determined by comparing women who had good or poor postoperative recovery, defined by the global health NRS score. 12 The internal consistency, as measured using Cronbach's alpha and split-half reliability, was high. These values were within recommended limits (0.7e0.9), 18 and were comparable with those reported with QoR-15 2 and QoR-40. 1 The inter-item correlation also determined the internal consistency, with values indicating good correlation of items within ObsQoR-11, each adding its own dimension to the recovery status. The reproducibility (testeretest reliability) of ObsQoR-11 was excellent, with 82% of items having a correlation of >0.6. The short duration (30e60 min) between test and retest means that any meaningful improvement in recovery is unlikely to have occurred, but this was vulnerable to testeretest bias. The responsiveness of ObsQoR-11 (assessed using Cohen effect size and standardised response means to measure the relative size of postoperative change in ObsQoR-11 score) was excellent. ObsQoR-11 had a large Cohen effect size of 1.36 and a large standardised response mean of 0.85, suggesting significant differences in ObsQoR-11 score pre-and 24 h post-CD. These values are greater than QoR-40 and are comparable with QoR-15, supporting the ability of ObsQoR-11 to detect clinically significant differences in recovery, potentially making it useful in trials, quality improvement and clinical practice. Individual item effect sizes ranged from low to high, but most items had moderate to strong responsiveness. The acceptability and feasibility of ObsQoR-11 were very good. The median [IQR] time taken to complete the ObsQoR-22 questionnaire was 2 [2e3] min, and we anticipate the shorter ObsQoR-11 would be completed in significantly less time than this. The clinical brevity of ObsQoR-11 in practice may also make it less prone to bias from non-response.
There was only a weak correlation of pre-CD ObsQoR-11 to 24 h global health NRS scores. These results would not support the use of pre-ObsQoR-11 scores as a predictor of postoperative recovery in this setting. We, therefore, recommend this scoring tool be used for evaluation, not prediction, of postoperative recovery.
Our study had several limitations. The 66% response rate at 24 h was mainly attributable to women not being present at the planned interview time rather than refusal to complete the questionnaire. This makes our data vulnerable to selection bias, as we may have missed more women with a good 24 h recovery. It also highlights the difficulties in obtaining patientreported postoperative scores in obstetric clinical practice. Only 10% of women repeated the postoperative test at 25 h, which falls short of the 25% and 20% achieved by comparable evaluation studies. 2, 3 All interviews and patient interactions were conducted at a single university hospital in the UK that serves a multicultural population. This study only developed and evaluated ObsQoR-11. This instrument, therefore, still warrants further evaluation and validation, and also needs to be applied to other hospitals serving cohorts with different patient characteristics to determine the generalisability, and the application in the emergency CD and vaginal delivery settings. We excluded women unable to read or understand written English; therefore, validation of this scoring tool would also be required in other languages relevant to local patient characteristics. Pre-CD ObsQoR-11 scores were taken on the same day of surgery, in the morning, which may have influenced the baseline ObsQoR-11 scores because of the presence of anxiety and the effects of fasting and fatigue. We chose to measure QoR scores at 24 h post-CD, as this is becoming a desirable standard for discharge from hospitals with enhanced recovery programmes, as recommended by the National Institute for Health and Care Excellence. 19, 20 We did not test for the reproducibility of ObsQoR-11 beyond 25 h, as has been demonstrated for QoR-15 in day surgery. 3 In the future, we aim to validate ObsQoR-11 in the early (24e48 h), intermediate (1 week) , and late (6e8 weeks) recovery periods post-CD. In summary, we have developed an obstetric-specific recovery tool (ObsQoR-11) for use in patients undergoing CD, by adapting the QoR-40 questionnaire. ObsQoR-11 performed well in measures of reliability, responsiveness, clinical acceptability, and feasibility. The questionnaire appears to be an easy-to-use recovery outcome measure, which could be utilised as a standardised patient-centred tool to evaluate recovery and well-being in the obstetric population. However, future work is needed to validate ObsQoR-11, determine its generalisability, and evaluate its role in unplanned CD and after assisted vaginal delivery. Further testing for reproducibility beyond 24 h is desirable. In addition, exploring the relationship between ObsQoR-11 and other markers of recovery and postoperative morbidity would further validate this instrument.
